Literature DB >> 22038340

Cancer mortality among atomic bomb survivors exposed as children.

Hitomi Goto1, Tomoyuki Watanabe, Masaru Miyao, Hiromi Fukuda, Yuzo Sato, Yoshiharu Oshida.   

Abstract

OBJECTIVES: To compare cancer mortality among A-bomb survivors exposed as children with cancer mortality among an unexposed control group (the entire population of Japan, JPCG).
METHODS: The subjects were the Hiroshima and Nagasaki A-bomb survivor groups (0-14 years of age in 1945) reported in life span study report 12 (follow-up years were from 1950 to 1990), and a control group consisting of the JPCG. We estimated the expected number of deaths due to all causes and cancers of various causes among the exposed survivors who died in the follow-up interval, if they had died with the same mortality as the JPCG (0-14 years of age in 1945). We calculated the standardized mortality ratio (SMR) of A-bomb survivors in comparison with the JPCG.
RESULTS: SMRs were significantly higher in exposed boys overall for all deaths, all cancers, leukemia, and liver cancer, and for exposed girls overall for all cancers, solid cancers, liver cancer, and breast cancer. In boys, SMRs were significantly higher for all deaths and liver cancer even in those exposed to very low doses, and for all cancers, solid cancers, and liver cancer in those exposed to low doses. In girls, SMRs were significantly higher for liver cancer and uterine cancer in those exposed to low doses, and for leukemia, solid cancers, stomach cancer, and breast cancer in those exposed to high doses.
CONCLUSIONS: We calculated the SMRs for the A-bomb survivors versus JPCG in childhood and compared them with a true non-exposed group. A notable result was that SMRs in boys exposed to low doses were significantly higher for solid cancer.

Entities:  

Mesh:

Year:  2011        PMID: 22038340      PMCID: PMC3348246          DOI: 10.1007/s12199-011-0246-6

Source DB:  PubMed          Journal:  Environ Health Prev Med        ISSN: 1342-078X            Impact factor:   3.674


  15 in total

1.  Associations between childhood cancer and ionizing radiation: results of a population-based case-control study in Germany.

Authors:  R Meinert; U Kaletsch; P Kaatsch; J Schüz; J Michaelis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-09       Impact factor: 4.254

2.  Answer to the comments by Eric J. Grant et al. in "Radiation unlikely to be responsible for high cancer rates among distal Hiroshima A-bomb survivors".

Authors:  Masaru Miyao; Tomoyuki Watanabe; Ryumon Honda; Yuichi Yamada
Journal:  Environ Health Prev Med       Date:  2009-05-02       Impact factor: 3.674

3.  Hiroshima survivors exposed to very low doses of A-bomb primary radiation showed a high risk for cancers.

Authors:  Tomoyuki Watanabe; Masaru Miyao; Ryumon Honda; Yuichi Yamada
Journal:  Environ Health Prev Med       Date:  2008-07-05       Impact factor: 3.674

4.  Cancer mortality among atomic bomb survivors exposed in utero or as young children, October 1950-May 1992.

Authors:  R R Delongchamp; K Mabuchi; Y Yoshimoto; D L Preston
Journal:  Radiat Res       Date:  1997-03       Impact factor: 2.841

Review 5.  Childhood and adult cancer after intrauterine exposure to ionizing radiation.

Authors:  J D Boice; R W Miller
Journal:  Teratology       Date:  1999-04

6.  Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990.

Authors:  D A Pierce; Y Shimizu; D L Preston; M Vaeth; K Mabuchi
Journal:  Radiat Res       Date:  1996-07       Impact factor: 2.841

Review 7.  Epidemiology and genetics of childhood cancer.

Authors:  Charles A Stiller
Journal:  Oncogene       Date:  2004-08-23       Impact factor: 9.867

8.  Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 1. Comparison of risk coefficients for site-specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses.

Authors:  Y Shimizu; H Kato; W J Schull; D L Preston; S Fujita; D A Pierce
Journal:  Radiat Res       Date:  1989-06       Impact factor: 2.841

9.  A cohort study of childhood cancer incidence after postnatal diagnostic X-ray exposure.

Authors:  Gaël P Hammer; Michael C Seidenbusch; Karl Schneider; Dieter F Regulla; Hajo Zeeb; Claudia Spix; Maria Blettner
Journal:  Radiat Res       Date:  2009-04       Impact factor: 2.841

10.  Solid cancer incidence in atomic bomb survivors exposed in utero or as young children.

Authors:  Dale L Preston; Harry Cullings; Akihiko Suyama; Sachiyo Funamoto; Nobuo Nishi; Midori Soda; Kiyohiko Mabuchi; Kazunori Kodama; Fumiyoshi Kasagi; Roy E Shore
Journal:  J Natl Cancer Inst       Date:  2008-03-11       Impact factor: 13.506

View more
  5 in total

Review 1.  Reproduction and breast cancer risk.

Authors:  Volker Hanf; Dorothea Hanf
Journal:  Breast Care (Basel)       Date:  2014-12       Impact factor: 2.860

Review 2.  State of the evidence 2017: an update on the connection between breast cancer and the environment.

Authors:  Janet M Gray; Sharima Rasanayagam; Connie Engel; Jeanne Rizzo
Journal:  Environ Health       Date:  2017-09-02       Impact factor: 5.984

3.  Ionizing radiation exposure: hazards, prevention, and biomarker screening.

Authors:  Hongxiang Mu; Jing Sun; Linwei Li; Jie Yin; Nan Hu; Weichao Zhao; Dexin Ding; Lan Yi
Journal:  Environ Sci Pollut Res Int       Date:  2018-04-29       Impact factor: 4.223

4.  Non-thyroid cancer incidence in Belarusian residents exposed to Chernobyl fallout in childhood and adolescence: Standardized Incidence Ratio analysis, 1997-2011.

Authors:  Evgenia Ostroumova; Maureen Hatch; Alina Brenner; Eldar Nadyrov; Ilya Veyalkin; Olga Polyanskaya; Vasilina Yauseyenka; Semion Polyakov; Leonid Levin; Lydia Zablotska; Alexander Rozhko; Kiyohiko Mabuchi
Journal:  Environ Res       Date:  2016-02-03       Impact factor: 8.431

Review 5.  Pediatric Exposures to Ionizing Radiation: Carcinogenic Considerations.

Authors:  Kristy R Kutanzi; Annie Lumen; Igor Koturbash; Isabelle R Miousse
Journal:  Int J Environ Res Public Health       Date:  2016-10-28       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.